In an interview on CNBC’s Mad Money, Thermo Fisher CEO Marc Casper said: The Brammer Bio deal will help us build out our capabilities… A key element of our growth strategy is emerging markets… We are particularly strong in emerging markets… We have a very disciplined M&A process and we have a track record of creating value… Breakthrough science is coming from the U.S.
https://thefly.com/landingPageNews.php?id=2884039
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.